000			03289nam a22003735i 4500
001			81297
003			ES-MaUEC
005			20230207040323.0
007			cr nn 008mamaa
008			141202s2015 gw | s |||| 0|eng d
020			_a9783319122830
024	7		_a10.1007/978-3-319-12283-0 _2doi
050		4	_aRC372 _b.E655 2015
245	1	0	_aEpilepsy Towards the Next Decade : _bNew Trends and Hopes in Epileptology _cedited by Pasquale Striano.
260			_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (X, 238 páginas) _b40 ilustraciones, 21 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aContemporary Clinical Neuroscience
505	0		_aPreface -- Copy number variants and epilepsy: new emerging syndromes -- Mutations of ion channels in genetic epilepsies -- LGI1 dysfunction in inherited and acquired epileptic disorders -- Glioneuronal tumors and epilepsy: clinico-diagnostic features and surgical strategies -- Metabolic causes of epilepsy -- New insights into mechanisms underlying generalized reflex seizures -- Current status and future prospective of neuroimaging for epilepsy -- The complex relationship between epilepsy and headache and the concept of ictal epileptic headache -- Epilepsy and immune system: a tour around the current literature -- Novel molecular targets for drug-treatment of epilepsy -- Reproductive hormones in epilepsy therapy: from old promises to new hopes -- Neuromodulation for the treatment of drug-resistant epilepsy -- New radiosurgical paradigms to treat epilepsy using synchrotron radiation.
520	3		_aÂ{u2802}Â{u2802}Â{u0060}comprehensive collection of the most recent knowledge on the biological bases of various kinds of epilepsies and modern clinical approaches to their treatment. Epilepsy affects about 0.5-1% of the world's population (about 50,000,000 individuals)Â{u1BA4} the main goal of its treatment is to eliminate seizures without creating side effects. Â{u2802}Â{u2802}Âĥspite numerous advances in the treatment of epilepsy and the approval of several new antiepileptic drugs, about 30% of patients continue to experience recurrent seizures which are medically, physically, and/or socially disabling. The editor of this volume hopes that by bridging the gap between the fundamental biology of epilepsy and its clinical implications he might spur further research and treatment options.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
988			_aEBOOK, EBSPRINGER, asignarmaterias_11febrero
650		0	_9139894 _aPsicología clínica _0
650		7	_aPsiquiatría _0 _2embne _9139041
650		7	_aNeurociencias _0 _2embne _9158907
700	1		_aStriano, Pasquale _eeditor literario _993644 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-12283-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12898879 _b10-10-17 _c18-01-16
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC372 .E655 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11568495 _z06-04-17
999			_c81297 _d81297 _x1